AsianScientist (Feb. 15, 2016) – The National University of Singapore (NUS)’s Professor Lim Chwee Teck has been elected to the prestigious American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
Lim is a Provost’s Chair Professor at the Department of Biomedical Engineering and a Principal Investigator at the Mechanobiology Institute at NUS. His nomination was peer-reviewed by the College of Fellows Selection Committee.
Lim was unanimously elected to the Fellowship in recognition of his exceptional research efforts leading to the development of biomedical technologies that can directly benefit patient communities.
Established in 1991, AIMBE is a non-profit organization with a vision to improve lives and empower societies by advocating for public policy issues, and pioneering innovations in the field of medical and biological engineering.
The College of Fellows spearheads the various programs at AIMBE and is comprised of over 1,500 members including distinguished engineering and medical school chairs, research directors, professors, innovators and successful entrepreneurs, who represent the top two percent of the medical and biological engineering community.
“I am very honored to be elected as a Fellow of AIMBE. This is a very good recognition of the research effort that both my team and I have put in to develop biomedical technologies that we hope will directly benefit the patients,” said Lim, who will only be the third person from Singapore to be awarded the Fellowship since AIMBE’s inception. The other fellows are NUS’s Professor Seeram Ramakrishna and executive director of the Institute of Bioengineering and Nanotechnology Professor Jackie Ying.
“It will also serve as an impetus for us to continue to strive towards excellence in what we do.”
At NUS, Lim and his interdisciplinary research team apply mechanobiology principles in the study of human diseases such as cancer, malaria and aging. As well as striving to understand disease pathophysiology, they use state-of-the-art micro and nanotechnology to develop miniaturized devices ranging from microfluidic chips, tunable nanomaterials and wearable biosensors for the diagnosis, management and treatment of these diseases.
Furthermore, Lim’s innovative research has led to the creation of several successful startup companies, aimed at realizing his vision of translating biomedical technologies from the lab to the clinic for the benefit of society.
Source: Mechanobiology Institute; Photo: MechanoBioEngineering Laboratory.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.